These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. Whaley K; Schur PH; Ruddy S J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459 [TBL] [Abstract][Full Text] [Related]
5. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases. Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373 [TBL] [Abstract][Full Text] [Related]
6. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum. Ballow M; Fang F; Good RA; Day NK Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765 [TBL] [Abstract][Full Text] [Related]
7. Activation of the complement and properdin systems in rheumatoid arthritis. Ruddy S; Austen KF Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964 [TBL] [Abstract][Full Text] [Related]
8. [Activation of the complement system in different forms of glomerulonephritis]. Wegmüller E; Frey B; Hodler J Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469 [TBL] [Abstract][Full Text] [Related]
9. The biological role of the complement system and the clinical importance of complement measurements. Füst G Haematologia (Budap); 1978-1979; 12(1-4):85-106. PubMed ID: 395046 [TBL] [Abstract][Full Text] [Related]
10. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway. Fearon DT; Austen KF; Ruddy S Rheumatology; 1975; 6():2-16. PubMed ID: 1105744 [No Abstract] [Full Text] [Related]
11. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus. Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the component and regulatory proteins of the classical pathway C3 convertase. Welch TR; Forristal J; Beischel L J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565 [TBL] [Abstract][Full Text] [Related]
13. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients. Munthe E; Hoyeraal HM; Froland SS; Mellbye OJ; Kåss E; Natvig JB Rheumatology; 1975; 6():43-51. PubMed ID: 1081730 [TBL] [Abstract][Full Text] [Related]
14. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis. Hunder GG; McDuffie FC; Clark RJ J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858 [TBL] [Abstract][Full Text] [Related]
15. Alternative pathway complement activation in rheumatoid arthritis. El-Ghobarey A; Whaley K J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571 [TBL] [Abstract][Full Text] [Related]
16. Immune complexes and complement in rheumatoid arthritis. Lambert PH; Casali P; Nydegger U Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786 [TBL] [Abstract][Full Text] [Related]
17. Clinical applications of complement measurements in rheumatic diseases. Goldstein IM Am J Med Sci; 1975; 269(2):172-82. PubMed ID: 1096603 [TBL] [Abstract][Full Text] [Related]
18. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid. Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA Rheumatology; 1975; 6():52-9. PubMed ID: 1202608 [TBL] [Abstract][Full Text] [Related]